Eastwood Bio-Medical Canada Inc. (EWOOF)
Stock analysis · OTC · Consumer Defensive · Food Distribution
Eastwood Bio-Medical Canada Inc. (EWOOF) is a publicly traded company in the Consumer Defensive sector. Latest price: $0.69. Market cap $47.79M. Trailing PE -169.95. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. specializes in the marketing and distribution of natural health products under its proprietary Eleotin brand. The company's reach extends across Canada, the United States, and Asia. Its primary focus is on providing natural remedies for metabolic health concerns, such as blood glucose imbalances, high blood pressure, and obesity. The diverse Eleotin product range includes several licensed formulations: Eleotin A 700: Addresses spleen deficiency, poor appetite, and fatigue. Eleotin AL88: Functions as a laxative. Eleotin Cal20 & V3D: Both contribute to the development and maintenance of healthy bones and teeth, with V3D additionally promoting overall good health. Eleotin G2000: Supports cardiovascular well-being. Eleotin H55: Offers sedative effects and helps alleviate tension. Eleotin Zn330: Aids in tissue formation and metabolism. Additionally, the company offers Eleotin Bentley to assist in maintaining healthy glucose levels and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was founded in 2010 and is based in Richmond, Canada.
Valuation
| P/E (TTM) | -169.95× |
|---|---|
| P/S (TTM) | 76.88× |
| P/B | -79.36× |
| PEG | 6.06× |
| P/FCF (TTM) | -3951.30× |
| EV / EBITDA | -162.63× |
| EV / Sales | 76.93× |
| Earnings Yield | -0.82% |
| Free Cash Flow Yield | -0.03% |
Fundamentals
| Enterprise Value | $66.77M |
|---|---|
| Revenue (TTM) | $867.94K |
| Net Income (TTM) | -$546.60K |
| Free Cash Flow (TTM) | $11.28K |
| Net Debt | $43.52K |
| Working Capital | -$1.18M |
| Gross Margin | 63.18% |
| Operating Margin | -58.21% |
| Net Margin | -62.98% |
| Return on Equity | 96.32% |
| Return on Invested Capital | 64.87% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap